Featured

Fosaprepitant Improves Standard Pediatric Antiemetic Therapy

Single-dose fosaprepitant in addition to the standard regimen of granisetron and dexamethasone appears to be safe for pediatric use.

ASH 2017 News

Read our coverage of the 59th ASH Annual Meeting and Exposition.

Coverage of SABCS 2017

Our continuing coverage of the 2017 San Antonio Breast Cancer Symposium.

Colorectal Cancer and Dietary Fiber

Adhering to a fiber-rich diet is an action survivors can take to better manage their health.

2018 ONA Navigation Summit

Join us in Chicago, Illinois for the 4th annual Summit.

Personalized Care in Advanced Breast Cancer

Earn credits and learn about CDK4/6 and PARP inhibitors and immunotherapies.

Let Us Answer Your Oncology Question

Submit your oncology question today and let our experts respond!

Immunotherapies: Biomarkers to Immune-Related AEs

Earn credits and learn more about latest data on predictive biomarkers.

Features

Oncology Nursing

Cardiac Care in the Oncology Setting

Cardio-oncology is an emerging interdisciplinary practice poised to address care patients who need concurrent cancer and cardiovascular disease therapies as well as the late effects of cancer and cancer treatments.

Side-Effect Management

Opioid Epidemic Response Affects Cancer Pain Management

A report on current legislation and practice trends regarding opioids and how they are affecting cancer patients' ability to manage their pain.

Advisor Forum

MDS, AML a Risk With PARP Inhibitors in BRCA Mutation Carriers

MDS, AML a Risk With PARP Inhibitors in BRCA Mutation Carriers

What is the concern behind PARP inhibitors and leukemia?

FDA Discontinues ESA APPRISE Risk Evaluation and Mitigation Strategy Program

FDA Discontinues ESA APPRISE Risk Evaluation and Mitigation Strategy Program

Why was the ESA APPRISE risk evaluation and mitigation strategy program discontinued?

New Class of Clinical Trial Enhances Research on Cancer Care Delivery

New Class of Clinical Trial Enhances Research on Cancer Care Delivery

What is a CCDR clinical trial and how does it differ from clinical trials that test new drugs?

Fact Sheets

Reproductive History and Cancer Risk (Fact Sheet)

Reproductive History and Cancer Risk (Fact Sheet)

This fact sheet examines possible correlations between cancer risk and factors such as pregnancy and breast feeding.

HPV and Cancer (Fact Sheet)

HPV and Cancer (Fact Sheet)

This fact sheet examines possible links between human papillomaviruses (HPVs) and cancer.

Digital Issue

Editorial Board

Ann J. Brady, MSN, RN-BC

Jiajoyce R. Conway, DNP, FNP-BC, AOCNP

Marianne Davies, DNP, ACNP, AOCNP

Frank dela Rama, RN, MS, AOCNS

Donald R. Fleming, MD

Susanne Menon, MP, OCN

Leah A. Scaramuzzo, MSN, RN-BC, AOCN

Lisa A. Thompson, PharmD, BCOP

Rosemarie A. Tucci, RN, MSN, AOCN


     .

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs